Search clinical trials for: Human Normal Immunoglobulin for Subcutaneous Administration
Total 192 results
-
CSL BehringCompletedPrimary Immune DeficiencyUnited States
-
CSL BehringCompletedCommon Variable Immunodeficiency | X-linked Agammaglobulinemia | Autosomal Recessive AgammaglobulinemiaGermany, United Kingdom, France, Italy, Poland, Romania, Spain, Sweden, Switzerland
-
Laboratoire français de Fractionnement et de BiotechnologiesTFS Trial Form SupportCompletedMotor Neuron DiseaseSpain, United Kingdom, Italy, France
-
Biopharma Plasma LLCLviv National Medical University; Vinnitsa National Medical UniversityCompleted
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)Germany, Austria, Hungary, Sweden, United Kingdom
-
Thomas Jefferson UniversityTerminatedDermatomyositisUnited States
-
University of AlbertaOctapharmaRecruitingPrimary Immune Deficiency Disorder | Secondary Immune DeficiencyCanada
-
Rigshospitalet, DenmarkAarhus University Hospital; Octapharma Pharmazeutika Produktionsges.m.b.H.CompletedChronic Inflammatory Demyelinating Polyneuropathy | Hemolytic Anemia | Multifocal Motor NeuropathyDenmark
-
University of AlbertaCSL BehringCompleted
-
Bio Products LaboratoryCompleted
-
Assistance Publique - Hôpitaux de ParisCSL Behring; Association ASLUMARECompleted
-
CSL BehringCompletedMultifocal Motor Neuropathy (MMN)Switzerland, Italy, United Kingdom
-
Bio Products LaboratoryCompletedPrimary or Secondary Antibody DeficiencyUnited Kingdom
-
Wei WangUnknownIntracranial Hemorrhage, HypertensiveChina
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited States, United Kingdom
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedExposure During PregnancyPoland, Czechia, United States, Germany, Slovakia
-
OctapharmaPremier Research Group plcCompletedPrimary Immunodeficiency DiseasesUnited States
-
Bio Products LaboratoryCompletedPrimary Antibody DeficiencyUnited Kingdom
-
OctapharmaCompletedImmune Thrombocytopenic PurpuraAustria
-
GWT-TUD GmbHCompletedPrimary Immunodeficiency | Secondary Immune DeficiencyGermany, Italy, France
-
Peking Union Medical College HospitalTongji HospitalUnknown
-
Cedars-Sinai Medical CenterCompletedType 2 Diabetes Mellitus | AcromegalyUnited States
-
CSL BehringWithdrawnDiffuse Cutaneous Systemic SclerosisBelgium, United States, Italy, Spain, France, Germany, United Kingdom, Argentina, Australia, Canada, Mexico, Poland, Switzerland
-
Baxalta now part of ShireCompleted
-
Rochester General HospitalTakedaRecruitingCOPD Exacerbation AcuteUnited States
-
TakedaTakeda Development Center Americas, Inc.RecruitingPrimary Immunodeficiency Diseases (PID)United States
-
Sinopharm Wuhan Plasma-derived Biotherapies Co....China National Biotec Group Company Limited; Beijing Tiantan Biological Products...Not yet recruitingCOVID-19United Arab Emirates
-
Grifols Therapeutics LLCRecruitingBacterial Infections | B-cell Chronic Lymphocytic Leukemia | HypogammaglobulinemiaUnited States, Bulgaria, Poland, Romania, Serbia
-
University of WashingtonTG Therapeutics, Inc.TerminatedHodgkin's LymphomaUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Spain, Netherlands, Sweden, Denmark, France
-
University of South FloridaCSL BehringCompletedChronic Inflammatory Demyelinating PolyneuropathyUnited States
-
Baxalta now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)Japan
-
SAb Biotherapeutics, Inc.Biomedical Advanced Research and Development Authority; Joint Program Executive...Active, not recruitingCOVID-19 | SARS-CoV2United States
-
SAb Biotherapeutics, Inc.Department of Health and Human Services; JPEO, Chemical, Biological, Radiological...CompletedCOVID-19 | SARS-CoV2United States
-
CSL BehringCompletedPrimary Immune Deficiency DisorderJapan
-
Changchun BCHT Biotechnology Co.The First Affiliated Hospital of Yunnan University of Traditional Chinese... and other collaboratorsNot yet recruitingRabies Virus InfectionChina
-
CSL BehringCompleted
-
TakedaTakeda Development Center Americas, Inc.; Baxalta Innovations GmbH, now part...Completed
-
Inova Health Care ServicesCSL BehringWithdrawn
-
TakedaTakeda Development Center Americas, Inc.Not yet recruitingPrimary Immunodeficiency Diseases (PID)
-
Mazen Dimachkie, MDCSL BehringCompletedMyasthenia GravisUnited States, Canada
-
Grifols Therapeutics LLCCompletedPrimary ImmunodeficiencySpain, France, Germany, United Kingdom, Australia, Czechia, Hungary, Poland, Sweden
-
Emergent BioSolutionsCompletedInfluenza A H3N2 | Influenza A H1N1United States, Spain, Canada, Puerto Rico
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedMLH1 Gene Mutation | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Metastatic Carcinoma in the Liver | MSH6 Gene Mutation | PMS2 Gene MutationUnited States
-
Grifols Therapeutics LLCCompleted
-
CSL BehringCompletedPrimary Immune Deficiency | Secondary Immune DeficiencyCanada
-
Fred Hutchinson Cancer CenterRecruitingHematopoietic and Lymphoid System Neoplasm | Hematologic and Lymphocytic DisorderUnited States
-
Lifefactors Zona Franca, SASUnknownCoronavirus Disease 2019 (COVID-19)Colombia
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedPrimary Immunodeficiency Diseases (PID)Canada